ARVN
Price
$17.77
Change
-$0.60 (-3.27%)
Updated
Feb 21 closing price
Capitalization
1.26B
73 days until earnings call
KYMR
Price
$36.81
Change
-$0.61 (-1.63%)
Updated
Feb 21 closing price
Capitalization
2.38B
68 days until earnings call
Ad is loading...

ARVN vs KYMR

Header iconARVN vs KYMR Comparison
Open Charts ARVN vs KYMRBanner chart's image
Arvinas
Price$17.77
Change-$0.60 (-3.27%)
Volume$1.87M
Capitalization1.26B
Kymera Therapeutics
Price$36.81
Change-$0.61 (-1.63%)
Volume$397.35K
Capitalization2.38B
ARVN vs KYMR Comparison Chart
Loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARVN vs. KYMR commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARVN is a Hold and KYMR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ARVN: $17.77 vs. KYMR: $36.81)
Brand notoriety: ARVN and KYMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ARVN: 189% vs. KYMR: 81%
Market capitalization -- ARVN: $1.26B vs. KYMR: $2.38B
ARVN [@Biotechnology] is valued at $1.26B. KYMR’s [@Biotechnology] market capitalization is $2.38B. The market cap for tickers in the [@Biotechnology] industry ranges from $369.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARVN’s FA Score shows that 0 FA rating(s) are green whileKYMR’s FA Score has 0 green FA rating(s).

  • ARVN’s FA Score: 0 green, 5 red.
  • KYMR’s FA Score: 0 green, 5 red.
According to our system of comparison, ARVN is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARVN’s TA Score shows that 1 TA indicator(s) are bullish while KYMR’s TA Score has 4 bullish TA indicator(s).

  • ARVN’s TA Score: 1 bullish, 5 bearish.
  • KYMR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, KYMR is a better buy in the short-term than ARVN.

Price Growth

ARVN (@Biotechnology) experienced а -2.95% price change this week, while KYMR (@Biotechnology) price change was -0.19% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ARVN is expected to report earnings on May 06, 2025.

KYMR is expected to report earnings on May 01, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($2.38B) has a higher market cap than ARVN($1.26B). ARVN YTD gains are higher at: -7.303 vs. KYMR (-8.501). KYMR has higher annual earnings (EBITDA): -160.96M vs. ARVN (-350.6M). ARVN has more cash in the bank: 1.12B vs. KYMR (550M). ARVN has less debt than KYMR: ARVN (1.5M) vs KYMR (88.2M). ARVN has higher revenues than KYMR: ARVN (161M) vs KYMR (87.6M).
ARVNKYMRARVN / KYMR
Capitalization1.26B2.38B53%
EBITDA-350.6M-160.96M218%
Gain YTD-7.303-8.50186%
P/E RatioN/AN/A-
Revenue161M87.6M184%
Total Cash1.12B550M204%
Total Debt1.5M88.2M2%
FUNDAMENTALS RATINGS
ARVN: Fundamental Ratings
ARVN
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
36
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
87
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ARVNKYMR
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
88%
Advances
ODDS (%)
Bullish Trend 5 days ago
80%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 5 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
View a ticker or compare two or three
Ad is loading...
ARVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ABCSX16.94N/A
N/A
AB Discovery Value C
TGSAX9.67N/A
N/A
Templeton Global Smaller Comp Adv
NBRTX26.74N/A
N/A
Neuberger Berman M/C Intrinsic Val Inst
HGXRX15.94N/A
N/A
Hartford Global Impact R3
RGLAX24.35-0.28
-1.14%
American Funds Global Insight R-1

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-1.63%
CCCC - KYMR
60%
Loosely correlated
+0.67%
IMNM - KYMR
49%
Loosely correlated
-5.84%
ERAS - KYMR
48%
Loosely correlated
-3.42%
ATXS - KYMR
48%
Loosely correlated
-0.15%
XENE - KYMR
47%
Loosely correlated
+0.89%
More